Evidence map›Paper›PMID 40830036›Full record

ArticleArchives of disease in childhood. Fetal and neonatal edition2026

Histological chorioamnionitis and neurodevelopment at 5 years of age among infants born very preterm: EPIPAGE-2 cohort study.

Fanny Salmon, Mathilde Letouzey, Laetitia Marchand-Martin, Héloïse Torchin, Valérie Benhammou, Kaminski Monique, Véronique Pierrat, Laurence Foix-L'Helias, Pierre Yves Ancel, Elsa Lorthe and 3 more

Abstract read
In one paragraph

Article in Archives of disease in childhood. Fetal and neonatal edition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Fanny SalmonUMR 1153, CRESS, Obstetric, Perinatal, and Pediatric Life course Epidemiology, OPPaLE Team, INSERM, Paris, France fanny.salmon@inserm.fr.ORCID http://orcid.org/0000-0001-5222-4266
Mathilde LetouzeyUMR 1153, CRESS, Obstetric, Perinatal, and Pediatric Life course Epidemiology, OPPaLE Team, INSERM, Paris, France.ORCID http://orcid.org/0000-0003-0577-4251
Laetitia Marchand-MartinUMR 1153, CRESS, Obstetric, Perinatal, and Pediatric Life course Epidemiology, OPPaLE Team, INSERM, Paris, France.ORCID http://orcid.org/0000-0002-8036-8387
Héloïse TorchinUMR 1153, CRESS, Obstetric, Perinatal, and Pediatric Life course Epidemiology, OPPaLE Team, INSERM, Paris, France.ORCID http://orcid.org/0000-0003-4699-5384
Valérie BenhammouUMR 1153, CRESS, Obstetric, Perinatal, and Pediatric Life course Epidemiology, OPPaLE Team, INSERM, Paris, France.
Kaminski MoniqueUMR 1153, CRESS, Obstetric, Perinatal, and Pediatric Life course Epidemiology, OPPaLE Team, INSERM, Paris, France.
Véronique PierratUMR 1153, CRESS, Obstetric, Perinatal, and Pediatric Life course Epidemiology, OPPaLE Team, INSERM, Paris, France.ORCID http://orcid.org/0000-0001-7435-5144
Laurence Foix-L'HeliasUMR 1153, CRESS, Obstetric, Perinatal, and Pediatric Life course Epidemiology, OPPaLE Team, INSERM, Paris, France.
Pierre Yves AncelUMR 1153, CRESS, Obstetric, Perinatal, and Pediatric Life course Epidemiology, OPPaLE Team, INSERM, Paris, France.
Elsa LortheUMR 1153, CRESS, Obstetric, Perinatal, and Pediatric Life course Epidemiology, OPPaLE Team, INSERM, Paris, France.
Gilles KayemUMR 1153, CRESS, Obstetric, Perinatal, and Pediatric Life course Epidemiology, OPPaLE Team, INSERM, Paris, France.
EPIPAGE 2 Study-group
EPIPAGE-2 Working group on infections

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the association between histological chorioamnionitis without maternal clinical symptoms and neurodevelopmental disabilities at age 5 years in children born very preterm.

designFrench national prospective population-based cohort study, EPIPAGE-2 (

settingAll births from 22 to 34 weeks of gestational age in France in 2011 were eligible. POPULATION: Infants born alive between 24 EXPOSURE: Histological chorioamnionitis without maternal clinical symptoms, also called isolated histological chorioamnionitis, was defined as the presence of neutrophils in the chorionic plate, excluding clinical chorioamnionitis.

main outcome measuresNeurodevelopmental disabilities, a composite outcome including cerebral palsy, developmental coordination disorders, sensory impairment, developmental cognitive deficiencies or behavioural difficulties. These assessments were comprehensive, standardised and conducted by trained neuropsychologists and paediatricians at age 5 years.

resultsAmong 1296 children alive at 5 years of age, 486 (36.3%) were born in a context of isolated histological chorioamnionitis. Overall, 47% vs 33.6% of children exposed and not exposed to isolated histological chorioamnionitis had mild neurodevelopmental disabilities, and 13.8% vs 13.3% had moderate-to-severe neurodevelopmental disabilities. After multiple imputation and multivariable analysis, isolated histological chorioamnionitis was found not to be associated with the occurrence of mild or moderate-to-severe neurodevelopmental disabilities (adjusted OR: 1.0, 95% CI: 0.7 to 1.4 and 0.9, 0.6 to 1.2).

conclusionWe did not find any association between isolated histological chorioamnionitis and neurodevelopmental disabilities at age 5 years in children born very preterm after PTL or PPROM.

Indexed as

ChorioamnionitisDevelopmental DisabilitiesInfant, Extremely PrematureNeurodevelopmental DisordersChild, PreschoolCohort StudiesFemaleFranceGestational AgeHumansInfant, NewbornMalePregnancyPremature Rupture of Fetal MembranesProspective StudiesChild DevelopmentEpidemiologyFollow-Up Studies

Identifiers

PMID40830036
PMCPMC13018788

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.